C7A.019
Malignant carcinoid tumor of the small intestine, unspecified portion
Clinical Classification Guidelines
Medical Intelligence & Overview
A malignant carcinoid tumor of the small intestine is a rare type of cancer that develops in the neuroendocrine cells of the small intestine. These tumors are characterized by their ability to produce hormones and other chemical substances that can affect the body. The term 'malignant' indicates that the tumor has cancerous properties and can spread to other parts of the body. When the specific part of the small intestine isn't specified, it is classified under ICD-10 code C7A.019. Early detection and management are crucial as they can influence treatment options and outcomes.
Causes & Symptoms
Clinical Causes: Genetic factors and family history Certain inherited syndromes such as Multiple Endocrine Neoplasia (MEN) syndrome Chronic inflammation or other longstanding health conditions affecting the intestine Environmental factors like exposure to carcinogens, though specific causes are not well understood
Key Symptoms: Abdominal pain or discomfort A feeling of fullness or bloating in the abdomen Unexplained weight loss Diarrhea or changes in bowel habits Blood in the stool Carcinoid syndrome symptoms such as flushing, wheezing, and sweating (caused by hormone secretion from the tumor) in some cases
Diagnostic & Treatment
Diagnosis Path: The diagnostic process may include several steps to identify and assess the tumor: - Imaging tests such as CT scans, MRI, and somatostatin receptor scintigraphy (Octreoscan) help detect tumors and their spread. - Endoscopic procedures to visualize the small intestine and obtain tissue biopsies. - Laboratory tests measuring hormone levels in the blood and urine to detect functional tumors. - Histopathological examination of biopsy samples to confirm the diagnosis and evaluate tumor characteristics. - Additional tests might be necessary to determine the extent or stage of cancer, guiding treatment planning.
Treatment Protocols: Management of malignant carcinoid tumors can vary depending on the tumor's size, location, and whether it has spread. Typical treatment approaches include: - Surgical removal of the tumor, which is often the primary treatment. - Medications such as somatostatin analogs (e.g., octreotide) to control hormone-related symptoms and slow tumor growth. - Targeted therapies or chemotherapy for advanced cases or tumors that do not respond to initial treatments. - Regular follow-up examinations to monitor for recurrence or progression. - Supportive care to manage symptoms and improve quality of life.
Clinical Advice & FAQs
Billing Guidance
Is C7A.019 a billable ICD-10 code?
Yes, C7A.019 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C7A.019?
Clinical documentation must specify the nature of Malignant carcinoid tumor of the small intestine, unspecified portion and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
